Monday, September 30, 2019

Natco Pharma gets EIR from USFDA for Hyderabad facility

Natco Pharma gets EIR from USFDA for Hyderabad facility In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.

from Moneycontrol Business News https://ift.tt/2niYPBw

No comments:

Post a Comment

Best Agrolife acquires 100% stake in Sudarshan Farm Chemicals for Rs 139 crore

The acquisition will enable BAL to leverage SFCL#39;s proficiency in developing cost-effective and distinctive manufacturing routes for off...